Global Celiac Disease Drug Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Celiac Disease Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Celiac Disease Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Celiac Disease Drug by Country/Region, 2017, 2022 & 2028

2.2 Celiac Disease Drug Segment by Type

2.2.1 Distension

2.2.2 Diarrhea

2.2.3 Anorexia

2.2.4 Others

2.3 Celiac Disease Drug Sales by Type

2.3.1 Global Celiac Disease Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Celiac Disease Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Celiac Disease Drug Sale Price by Type (2017-2022)

2.4 Celiac Disease Drug Segment by Application

2.4.1 First Line of Treatment

2.4.2 Second Line of Treatment

2.5 Celiac Disease Drug Sales by Application

2.5.1 Global Celiac Disease Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Celiac Disease Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Celiac Disease Drug Sale Price by Application (2017-2022)

3 Global Celiac Disease Drug by Company

3.1 Global Celiac Disease Drug Breakdown Data by Company

3.1.1 Global Celiac Disease Drug Annual Sales by Company (2020-2022)

3.1.2 Global Celiac Disease Drug Sales Market Share by Company (2020-2022)

3.2 Global Celiac Disease Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Celiac Disease Drug Revenue by Company (2020-2022)

3.2.2 Global Celiac Disease Drug Revenue Market Share by Company (2020-2022)

3.3 Global Celiac Disease Drug Sale Price by Company

3.4 Key Manufacturers Celiac Disease Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Celiac Disease Drug Product Location Distribution

3.4.2 Players Celiac Disease Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Celiac Disease Drug by Geographic Region

4.1 World Historic Celiac Disease Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Celiac Disease Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Celiac Disease Drug Annual Revenue by Geographic Region

4.2 World Historic Celiac Disease Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Celiac Disease Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Celiac Disease Drug Annual Revenue by Country/Region

4.3 Americas Celiac Disease Drug Sales Growth

4.4 APAC Celiac Disease Drug Sales Growth

4.5 Europe Celiac Disease Drug Sales Growth

4.6 Middle East & Africa Celiac Disease Drug Sales Growth

5 Americas

5.1 Americas Celiac Disease Drug Sales by Country

5.1.1 Americas Celiac Disease Drug Sales by Country (2017-2022)

5.1.2 Americas Celiac Disease Drug Revenue by Country (2017-2022)

5.2 Americas Celiac Disease Drug Sales by Type

5.3 Americas Celiac Disease Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Celiac Disease Drug Sales by Region

6.1.1 APAC Celiac Disease Drug Sales by Region (2017-2022)

6.1.2 APAC Celiac Disease Drug Revenue by Region (2017-2022)

6.2 APAC Celiac Disease Drug Sales by Type

6.3 APAC Celiac Disease Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Celiac Disease Drug by Country

7.1.1 Europe Celiac Disease Drug Sales by Country (2017-2022)

7.1.2 Europe Celiac Disease Drug Revenue by Country (2017-2022)

7.2 Europe Celiac Disease Drug Sales by Type

7.3 Europe Celiac Disease Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Celiac Disease Drug by Country

8.1.1 Middle East & Africa Celiac Disease Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Celiac Disease Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Celiac Disease Drug Sales by Type

8.3 Middle East & Africa Celiac Disease Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Celiac Disease Drug

10.3 Manufacturing Process Analysis of Celiac Disease Drug

10.4 Industry Chain Structure of Celiac Disease Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Celiac Disease Drug Distributors

11.3 Celiac Disease Drug Customer

12 World Forecast Review for Celiac Disease Drug by Geographic Region

12.1 Global Celiac Disease Drug Market Size Forecast by Region

12.1.1 Global Celiac Disease Drug Forecast by Region (2023-2028)

12.1.2 Global Celiac Disease Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Celiac Disease Drug Forecast by Type

12.7 Global Celiac Disease Drug Forecast by Application

13 Key Players Analysis

13.1 F. Hoffmann-La Roche

13.1.1 F. Hoffmann-La Roche Company Information

13.1.2 F. Hoffmann-La Roche Celiac Disease Drug Product Offered

13.1.3 F. Hoffmann-La Roche Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 F. Hoffmann-La Roche Main Business Overview

13.1.5 F. Hoffmann-La Roche Latest Developments

13.2 Johnson & Johnson

13.2.1 Johnson & Johnson Company Information

13.2.2 Johnson & Johnson Celiac Disease Drug Product Offered

13.2.3 Johnson & Johnson Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Johnson & Johnson Main Business Overview

13.2.5 Johnson & Johnson Latest Developments

13.3 Merck

13.3.1 Merck Company Information

13.3.2 Merck Celiac Disease Drug Product Offered

13.3.3 Merck Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Merck Main Business Overview

13.3.5 Merck Latest Developments

13.4 Pfizer

13.4.1 Pfizer Company Information

13.4.2 Pfizer Celiac Disease Drug Product Offered

13.4.3 Pfizer Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Pfizer Main Business Overview

13.4.5 Pfizer Latest Developments

13.5 ADMA Biologics

13.5.1 ADMA Biologics Company Information

13.5.2 ADMA Biologics Celiac Disease Drug Product Offered

13.5.3 ADMA Biologics Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 ADMA Biologics Main Business Overview

13.5.5 ADMA Biologics Latest Developments

13.6 Amgen

13.6.1 Amgen Company Information

13.6.2 Amgen Celiac Disease Drug Product Offered

13.6.3 Amgen Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Amgen Main Business Overview

13.6.5 Amgen Latest Developments

13.7 Anthera Pharmaceuticals

13.7.1 Anthera Pharmaceuticals Company Information

13.7.2 Anthera Pharmaceuticals Celiac Disease Drug Product Offered

13.7.3 Anthera Pharmaceuticals Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Anthera Pharmaceuticals Main Business Overview

13.7.5 Anthera Pharmaceuticals Latest Developments

13.8 Bayer

13.8.1 Bayer Company Information

13.8.2 Bayer Celiac Disease Drug Product Offered

13.8.3 Bayer Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Bayer Main Business Overview

13.8.5 Bayer Latest Developments

13.9 Biogen

13.9.1 Biogen Company Information

13.9.2 Biogen Celiac Disease Drug Product Offered

13.9.3 Biogen Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Biogen Main Business Overview

13.9.5 Biogen Latest Developments

13.10 BioLineRx

13.10.1 BioLineRx Company Information

13.10.2 BioLineRx Celiac Disease Drug Product Offered

13.10.3 BioLineRx Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 BioLineRx Main Business Overview

13.10.5 BioLineRx Latest Developments

13.11 Biotest

13.11.1 Biotest Company Information

13.11.2 Biotest Celiac Disease Drug Product Offered

13.11.3 Biotest Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Biotest Main Business Overview

13.11.5 Biotest Latest Developments

13.12 Bristol-Myers Squibb

13.12.1 Bristol-Myers Squibb Company Information

13.12.2 Bristol-Myers Squibb Celiac Disease Drug Product Offered

13.12.3 Bristol-Myers Squibb Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Bristol-Myers Squibb Main Business Overview

13.12.5 Bristol-Myers Squibb Latest Developments

13.13 Celgene

13.13.1 Celgene Company Information

13.13.2 Celgene Celiac Disease Drug Product Offered

13.13.3 Celgene Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Celgene Main Business Overview

13.13.5 Celgene Latest Developments

13.14 Takeda Pharmaceutical

13.14.1 Takeda Pharmaceutical Company Information

13.14.2 Takeda Pharmaceutical Celiac Disease Drug Product Offered

13.14.3 Takeda Pharmaceutical Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Takeda Pharmaceutical Main Business Overview

13.14.5 Takeda Pharmaceutical Latest Developments

13.15 Novartis

13.15.1 Novartis Company Information

13.15.2 Novartis Celiac Disease Drug Product Offered

13.15.3 Novartis Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Novartis Main Business Overview

13.15.5 Novartis Latest Developments

13.16 LFB Group

13.16.1 LFB Group Company Information

13.16.2 LFB Group Celiac Disease Drug Product Offered

13.16.3 LFB Group Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 LFB Group Main Business Overview

13.16.5 LFB Group Latest Developments

13.17 Kedrion Biopharma

13.17.1 Kedrion Biopharma Company Information

13.17.2 Kedrion Biopharma Celiac Disease Drug Product Offered

13.17.3 Kedrion Biopharma Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Kedrion Biopharma Main Business Overview

13.17.5 Kedrion Biopharma Latest Developments

14 Research Findings and Conclusion

Table 1. Celiac Disease Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Celiac Disease Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Distension

Table 4. Major Players of Diarrhea

Table 5. Major Players of Anorexia

Table 6. Major Players of Others

Table 7. Global Celiac Disease Drug Sales by Type (2017-2022) & (K Pcs)

Table 8. Global Celiac Disease Drug Sales Market Share by Type (2017-2022)

Table 9. Global Celiac Disease Drug Revenue by Type (2017-2022) & ($ million)

Table 10. Global Celiac Disease Drug Revenue Market Share by Type (2017-2022)

Table 11. Global Celiac Disease Drug Sale Price by Type (2017-2022) & (USD/Pcs)

Table 12. Global Celiac Disease Drug Sales by Application (2017-2022) & (K Pcs)

Table 13. Global Celiac Disease Drug Sales Market Share by Application (2017-2022)

Table 14. Global Celiac Disease Drug Revenue by Application (2017-2022)

Table 15. Global Celiac Disease Drug Revenue Market Share by Application (2017-2022)

Table 16. Global Celiac Disease Drug Sale Price by Application (2017-2022) & (USD/Pcs)

Table 17. Global Celiac Disease Drug Sales by Company (2020-2022) & (K Pcs)

Table 18. Global Celiac Disease Drug Sales Market Share by Company (2020-2022)

Table 19. Global Celiac Disease Drug Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Celiac Disease Drug Revenue Market Share by Company (2020-2022)

Table 21. Global Celiac Disease Drug Sale Price by Company (2020-2022) & (USD/Pcs)

Table 22. Key Manufacturers Celiac Disease Drug Producing Area Distribution and Sales Area

Table 23. Players Celiac Disease Drug Products Offered

Table 24. Celiac Disease Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Celiac Disease Drug Sales by Geographic Region (2017-2022) & (K Pcs)

Table 28. Global Celiac Disease Drug Sales Market Share Geographic Region (2017-2022)

Table 29. Global Celiac Disease Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Celiac Disease Drug Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Celiac Disease Drug Sales by Country/Region (2017-2022) & (K Pcs)

Table 32. Global Celiac Disease Drug Sales Market Share by Country/Region (2017-2022)

Table 33. Global Celiac Disease Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Celiac Disease Drug Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Celiac Disease Drug Sales by Country (2017-2022) & (K Pcs)

Table 36. Americas Celiac Disease Drug Sales Market Share by Country (2017-2022)

Table 37. Americas Celiac Disease Drug Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Celiac Disease Drug Revenue Market Share by Country (2017-2022)

Table 39. Americas Celiac Disease Drug Sales by Type (2017-2022) & (K Pcs)

Table 40. Americas Celiac Disease Drug Sales Market Share by Type (2017-2022)

Table 41. Americas Celiac Disease Drug Sales by Application (2017-2022) & (K Pcs)

Table 42. Americas Celiac Disease Drug Sales Market Share by Application (2017-2022)

Table 43. APAC Celiac Disease Drug Sales by Region (2017-2022) & (K Pcs)

Table 44. APAC Celiac Disease Drug Sales Market Share by Region (2017-2022)

Table 45. APAC Celiac Disease Drug Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Celiac Disease Drug Revenue Market Share by Region (2017-2022)

Table 47. APAC Celiac Disease Drug Sales by Type (2017-2022) & (K Pcs)

Table 48. APAC Celiac Disease Drug Sales Market Share by Type (2017-2022)

Table 49. APAC Celiac Disease Drug Sales by Application (2017-2022) & (K Pcs)

Table 50. APAC Celiac Disease Drug Sales Market Share by Application (2017-2022)

Table 51. Europe Celiac Disease Drug Sales by Country (2017-2022) & (K Pcs)

Table 52. Europe Celiac Disease Drug Sales Market Share by Country (2017-2022)

Table 53. Europe Celiac Disease Drug Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Celiac Disease Drug Revenue Market Share by Country (2017-2022)

Table 55. Europe Celiac Disease Drug Sales by Type (2017-2022) & (K Pcs)

Table 56. Europe Celiac Disease Drug Sales Market Share by Type (2017-2022)

Table 57. Europe Celiac Disease Drug Sales by Application (2017-2022) & (K Pcs)

Table 58. Europe Celiac Disease Drug Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Celiac Disease Drug Sales by Country (2017-2022) & (K Pcs)

Table 60. Middle East & Africa Celiac Disease Drug Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Celiac Disease Drug Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Celiac Disease Drug Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Celiac Disease Drug Sales by Type (2017-2022) & (K Pcs)

Table 64. Middle East & Africa Celiac Disease Drug Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Celiac Disease Drug Sales by Application (2017-2022) & (K Pcs)

Table 66. Middle East & Africa Celiac Disease Drug Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Celiac Disease Drug

Table 68. Key Market Challenges & Risks of Celiac Disease Drug

Table 69. Key Industry Trends of Celiac Disease Drug

Table 70. Celiac Disease Drug Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Celiac Disease Drug Distributors List

Table 73. Celiac Disease Drug Customer List

Table 74. Global Celiac Disease Drug Sales Forecast by Region (2023-2028) & (K Pcs)

Table 75. Global Celiac Disease Drug Sales Market Forecast by Region

Table 76. Global Celiac Disease Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Celiac Disease Drug Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Celiac Disease Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 79. Americas Celiac Disease Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Celiac Disease Drug Sales Forecast by Region (2023-2028) & (K Pcs)

Table 81. APAC Celiac Disease Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Celiac Disease Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 83. Europe Celiac Disease Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Celiac Disease Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 85. Middle East & Africa Celiac Disease Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Celiac Disease Drug Sales Forecast by Type (2023-2028) & (K Pcs)

Table 87. Global Celiac Disease Drug Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Celiac Disease Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Celiac Disease Drug Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Celiac Disease Drug Sales Forecast by Application (2023-2028) & (K Pcs)

Table 91. Global Celiac Disease Drug Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Celiac Disease Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Celiac Disease Drug Revenue Market Share Forecast by Application (2023-2028)

Table 94. F. Hoffmann-La Roche Basic Information, Celiac Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 95. F. Hoffmann-La Roche Celiac Disease Drug Product Offered

Table 96. F. Hoffmann-La Roche Celiac Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 97. F. Hoffmann-La Roche Main Business

Table 98. F. Hoffmann-La Roche Latest Developments

Table 99. Johnson & Johnson Basic Information, Celiac Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 100. Johnson & Johnson Celiac Disease Drug Product Offered

Table 101. Johnson & Johnson Celiac Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 102. Johnson & Johnson Main Business

Table 103. Johnson & Johnson Latest Developments

Table 104. Merck Basic Information, Celiac Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 105. Merck Celiac Disease Drug Product Offered

Table 106. Merck Celiac Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 107. Merck Main Business

Table 108. Merck Latest Developments

Table 109. Pfizer Basic Information, Celiac Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 110. Pfizer Celiac Disease Drug Product Offered

Table 111. Pfizer Celiac Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 112. Pfizer Main Business

Table 113. Pfizer Latest Developments

Table 114. ADMA Biologics Basic Information, Celiac Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 115. ADMA Biologics Celiac Disease Drug Product Offered

Table 116. ADMA Biologics Celiac Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 117. ADMA Biologics Main Business

Table 118. ADMA Biologics Latest Developments

Table 119. Amgen Basic Information, Celiac Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 120. Amgen Celiac Disease Drug Product Offered

Table 121. Amgen Celiac Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 122. Amgen Main Business

Table 123. Amgen Latest Developments

Table 124. Anthera Pharmaceuticals Basic Information, Celiac Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 125. Anthera Pharmaceuticals Celiac Disease Drug Product Offered

Table 126. Anthera Pharmaceuticals Celiac Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 127. Anthera Pharmaceuticals Main Business

Table 128. Anthera Pharmaceuticals Latest Developments

Table 129. Bayer Basic Information, Celiac Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 130. Bayer Celiac Disease Drug Product Offered

Table 131. Bayer Celiac Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 132. Bayer Main Business

Table 133. Bayer Latest Developments

Table 134. Biogen Basic Information, Celiac Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 135. Biogen Celiac Disease Drug Product Offered

Table 136. Biogen Celiac Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 137. Biogen Main Business

Table 138. Biogen Latest Developments

Table 139. BioLineRx Basic Information, Celiac Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 140. BioLineRx Celiac Disease Drug Product Offered

Table 141. BioLineRx Celiac Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 142. BioLineRx Main Business

Table 143. BioLineRx Latest Developments

Table 144. Biotest Basic Information, Celiac Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 145. Biotest Celiac Disease Drug Product Offered

Table 146. Biotest Celiac Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 147. Biotest Main Business

Table 148. Biotest Latest Developments

Table 149. Bristol-Myers Squibb Basic Information, Celiac Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 150. Bristol-Myers Squibb Celiac Disease Drug Product Offered

Table 151. Bristol-Myers Squibb Celiac Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 152. Bristol-Myers Squibb Main Business

Table 153. Bristol-Myers Squibb Latest Developments

Table 154. Celgene Basic Information, Celiac Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 155. Celgene Celiac Disease Drug Product Offered

Table 156. Celgene Celiac Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 157. Celgene Main Business

Table 158. Celgene Latest Developments

Table 159. Takeda Pharmaceutical Basic Information, Celiac Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 160. Takeda Pharmaceutical Celiac Disease Drug Product Offered

Table 161. Takeda Pharmaceutical Celiac Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 162. Takeda Pharmaceutical Main Business

Table 163. Takeda Pharmaceutical Latest Developments

Table 164. Novartis Basic Information, Celiac Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 165. Novartis Celiac Disease Drug Product Offered

Table 166. Novartis Celiac Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 167. Novartis Main Business

Table 168. Novartis Latest Developments

Table 169. LFB Group Basic Information, Celiac Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 170. LFB Group Celiac Disease Drug Product Offered

Table 171. LFB Group Celiac Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 172. LFB Group Main Business

Table 173. LFB Group Latest Developments

Table 174. Kedrion Biopharma Basic Information, Celiac Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 175. Kedrion Biopharma Celiac Disease Drug Product Offered

Table 176. Kedrion Biopharma Celiac Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 177. Kedrion Biopharma Main Business

Table 178. Kedrion Biopharma Latest Developments

List of Figures

Figure 1. Picture of Celiac Disease Drug

Figure 2. Celiac Disease Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Celiac Disease Drug Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Celiac Disease Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Celiac Disease Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Distension

Figure 10. Product Picture of Diarrhea

Figure 11. Product Picture of Anorexia

Figure 12. Product Picture of Others

Figure 13. Global Celiac Disease Drug Sales Market Share by Type in 2021

Figure 14. Global Celiac Disease Drug Revenue Market Share by Type (2017-2022)

Figure 15. Celiac Disease Drug Consumed in First Line of Treatment

Figure 16. Global Celiac Disease Drug Market: First Line of Treatment (2017-2022) & (K Pcs)

Figure 17. Celiac Disease Drug Consumed in Second Line of Treatment

Figure 18. Global Celiac Disease Drug Market: Second Line of Treatment (2017-2022) & (K Pcs)

Figure 19. Global Celiac Disease Drug Sales Market Share by Application (2017-2022)

Figure 20. Global Celiac Disease Drug Revenue Market Share by Application in 2021

Figure 21. Celiac Disease Drug Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Celiac Disease Drug Revenue Market Share by Company in 2021

Figure 23. Global Celiac Disease Drug Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Celiac Disease Drug Revenue Market Share by Geographic Region in 2021

Figure 25. Global Celiac Disease Drug Sales Market Share by Region (2017-2022)

Figure 26. Global Celiac Disease Drug Revenue Market Share by Country/Region in 2021

Figure 27. Americas Celiac Disease Drug Sales 2017-2022 (K Pcs)

Figure 28. Americas Celiac Disease Drug Revenue 2017-2022 ($ Millions)

Figure 29. APAC Celiac Disease Drug Sales 2017-2022 (K Pcs)

Figure 30. APAC Celiac Disease Drug Revenue 2017-2022 ($ Millions)

Figure 31. Europe Celiac Disease Drug Sales 2017-2022 (K Pcs)

Figure 32. Europe Celiac Disease Drug Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Celiac Disease Drug Sales 2017-2022 (K Pcs)

Figure 34. Middle East & Africa Celiac Disease Drug Revenue 2017-2022 ($ Millions)

Figure 35. Americas Celiac Disease Drug Sales Market Share by Country in 2021

Figure 36. Americas Celiac Disease Drug Revenue Market Share by Country in 2021

Figure 37. United States Celiac Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Celiac Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Celiac Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Celiac Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Celiac Disease Drug Sales Market Share by Region in 2021

Figure 42. APAC Celiac Disease Drug Revenue Market Share by Regions in 2021

Figure 43. China Celiac Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Celiac Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Celiac Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Celiac Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Celiac Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Celiac Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Celiac Disease Drug Sales Market Share by Country in 2021

Figure 50. Europe Celiac Disease Drug Revenue Market Share by Country in 2021

Figure 51. Germany Celiac Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Celiac Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Celiac Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Celiac Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Celiac Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Celiac Disease Drug Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Celiac Disease Drug Revenue Market Share by Country in 2021

Figure 58. Egypt Celiac Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Celiac Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Celiac Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Celiac Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Celiac Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Celiac Disease Drug in 2021

Figure 64. Manufacturing Process Analysis of Celiac Disease Drug

Figure 65. Industry Chain Structure of Celiac Disease Drug

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles